ONO-4641 pill reduced number of MS lesions in Phase II trial
An investigational oral drug called ONO-4641 reduced the number of lesions in people with multiple sclerosis (MS), according to the results of a phase two clinical trial to be presented as Emerging Science (formerly known ...
Apr 16, 2012
0
0